The weekly litigation news digest is live. Subscribe now

IP Verse

C-Met Modulator Pharmaceutical Compositions - EP2593090

The patent EP2593090 was granted to Exelixis on Oct 13, 2021. The application was filed on Jul 18, 2011 under application number EP11740764A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2593090

EXELIXIS
Application Number
EP11740764A
Filing Date
Jul 18, 2011
Status
Granted And Under Opposition
Sep 10, 2021
Publication Date
Oct 13, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKJul 13, 2022TER MEER STEINMEISTER & PARTNERADMISSIBLE
STADA ARZNEIMITTELJul 12, 2022HAMM & WITTKOPPADMISSIBLE
TEVA PHARMACEUTICALSJul 12, 2022D YOUNGADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2005030140
DESCRIPTIONWO2008083319
DESCRIPTIONWO2010083414
INTERNATIONAL-SEARCH-REPORTWO2005030140
INTERNATIONAL-SEARCH-REPORTWO2010083414
OPPOSITIONWO2005030140
OPPOSITIONWO2010083414
OPPOSITIONWO2012009722

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents